EFFECT OF VITAMIN K ON VASCULAR HEALTH AND PHYSICAL FUNCTION IN OLDER PEOPLE WITH VASCULAR DISEASE - A RANDOMISED CONTROLLED TRIAL

被引:45
|
作者
Fulton, R. L. [1 ]
Mcmurdo, M. E. T. [1 ]
Hill, A. [1 ]
Abboud, R. J. [2 ]
Arnold, G. P. [2 ]
Struthers, A. D. [1 ]
Khan, F. [1 ]
Vermeer, C. [3 ]
Knapen, M. H. J. [3 ]
Drummen, N. E. A. [3 ]
Witham, M. D. [1 ]
机构
[1] Univ Dundee, Med Res Inst, Dundee DD1 4HN, Scotland
[2] Univ Dundee, Inst Mot Anal & Res, Dundee DD1 4HN, Scotland
[3] Maastricht Univ, VitaK, NL-6200 MD Maastricht, Netherlands
来源
JOURNAL OF NUTRITION HEALTH & AGING | 2016年 / 20卷 / 03期
关键词
Vitamin K; flow mediated dilatation; vascular health; physical function; older people; MATRIX GLA PROTEIN; IMPROVES ENDOTHELIAL FUNCTION; BRACHIAL-ARTERY; ELDERLY-PEOPLE; POSTURAL SWAY; RISK; SUPPLEMENTATION; ATHEROSCLEROSIS; DYSFUNCTION; SURVIVAL;
D O I
10.1007/s12603-015-0619-4
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background and Aims: Vitamin K insufficiency is common and linked to an increased risk of cardiovascular disease and osteoporotic fractures. The aim of this study was to examine whether daily supplementation with oral vitamin K could improve vascular health and physical function in older people with established vascular disease. Methods and results: A double blind, randomised, placebo-controlled trial. Participants aged <= 70 years with a history of vascular disease were randomised to receive 6 months of daily oral 100mcg vitamin K2 (MK7 subtype) or matching placebo with outcomes measured at 0, 3 and 6 months. The primary outcome was between-group difference in endothelial function assessed using flow-mediated dilatation of the brachial artery at 6 months. Secondary outcomes included carotid-radial pulse wave velocity, augmentation index, blood pressure, carotid intima-media thickness, C-reactive protein, B-type natriuretic peptide, cholesterol and desphospho-uncarboxylated matrix Gla protein levels. Handgrip strength and the Short Physical Performance Battery assessed physical function, while postural sway was measured using a 3-dimensional force platform. Results: 80 participants were randomised, mean age 77 (SD 5) years; 44/80 were male. Vitamin K levels rose in the intervention arm compared to placebo (+ 48 pg/ml vs -6 pg/ml, p=0.03) at 6 months. Desphosphouncarboxylated Matrix Gla protein levels fell in the intervention group compared to placebo at 6 months (-130 [ SD 117] pmol/L vs + 13 [ SD 180] pmol/L, p<0.001). No change was seen in endothelial function (between group difference -0.3% [ 95% CI -1.3 to 0.8], p=0.62). A modest, non-significant improvement in pulse wave velocity was seen in the vitamin K group (-0.8m/s [ 95% CI -1.8 to 0.3], p=0.15) while all other vascular and physical function outcomes unchanged. Conclusions: Six months of vitamin K2 supplementation did not improve markers of vascular health or physical function in older patients with vascular disease.
引用
收藏
页码:325 / 333
页数:9
相关论文
共 50 条
  • [21] Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial
    Bolland, Mark J.
    Barber, P. Alan
    Doughty, Robert N.
    Mason, Barbara
    Horne, Anne
    Ames, Ruth
    Gamble, Gregory D.
    Grey, Andrew
    Reid, Ian R.
    BMJ-BRITISH MEDICAL JOURNAL, 2008, 336 (7638): : 262 - 266
  • [22] DOES VITAMIN D SUPPLEMENTATION IMPROVE MARKERS OF VASCULAR HEALTH IN POST MYOCARDIAL INFARCTION PATIENTS? A RANDOMISED CONTROLLED TRIAL
    Witham, M. D.
    Dove, F. J.
    Khan, F.
    Lang, C. C.
    Belch, J. J. F.
    Struthers, A. D.
    AGE AND AGEING, 2012, 41 : 10 - 10
  • [23] Effect of Hot Flushes on Vascular Function A Randomized Controlled Trial
    Tuomikoski, Pauliina
    Ebert, Pia
    Groop, Per-Henrik
    Haapalahti, Petri
    Hautamaki, Hanna
    Ronnback, Mats
    Ylikorkala, Olavi
    Mikkola, Tomi S.
    OBSTETRICS AND GYNECOLOGY, 2009, 114 (04): : 777 - 785
  • [24] Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
    Shepherd, J
    Blauw, GJ
    Murphy, MB
    Bollen, ELEM
    Buckley, BM
    Cobbe, SM
    Ford, I
    Gaw, A
    Hyland, M
    Jukema, JW
    Kamper, AM
    Macfarlane, PW
    Meinders, AE
    Norrie, J
    Packard, CJ
    Perry, IJ
    Stott, DJ
    Sweeney, BJ
    Twomey, C
    Westendorp, RGJ
    LANCET, 2002, 360 (9346): : 1623 - 1630
  • [25] Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK - A randomised controlled trial
    Witham, Miles D.
    Adams, Fiona
    Kabir, Golam
    Kennedy, Gwen
    Belch, Jill J. F.
    Khan, Faisel
    ATHEROSCLEROSIS, 2013, 230 (02) : 293 - 299
  • [26] Internet based vascular risk factor management for patients with clinically manifest vascular disease: randomised controlled trial
    Vernooij, J. W. P.
    Kaasjager, H. A. H.
    van der Graaf, Y.
    Wierdsma, J.
    Grandjean, H. M. H.
    Hovens, M. M. C.
    de Wit, G. A.
    Visseren, F. L. J.
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [27] Effects of Oral Lycopene Supplementation on Vascular Function in Patients with Cardiovascular Disease and Healthy Volunteers: A Randomised Controlled Trial
    Gajendragadkar, Parag R.
    Hubsch, Annette
    Maeki-Petaejae, Kaisa M.
    Serg, Martin
    Wilkinson, Ian B.
    Cheriyan, Joseph
    PLOS ONE, 2014, 9 (06):
  • [28] Deprescribing in Frail Older People: A Randomised Controlled Trial
    Potter, Kathleen
    Flicker, Leon
    Page, Amy
    Etherton-Beer, Christopher
    PLOS ONE, 2016, 11 (03):
  • [29] Vitamin K and Calcium Chelation in Vascular Health
    Aaseth, Jan O.
    Alehagen, Urban
    Opstad, Trine Baur
    Alexander, Jan
    BIOMEDICINES, 2023, 11 (12)
  • [30] A randomised controlled trial of senior Lay Health Mentoring in older people with ischaemic heart disease: The Braveheart Project
    Coull, AJ
    Taylor, VH
    Elton, R
    Murdoch, PS
    Hargreaves, AD
    AGE AND AGEING, 2004, 33 (04) : 348 - 354